- Home
- EFR vs FULC Comparison
EFR vs FULC Comparison
Compare EFR & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFR
- FULC
- Stock Information
- Founded
- EFR 2003
- FULC 2015
- Country
- EFR United States
- FULC United States
- Employees
- EFR N/A
- FULC N/A
- Industry
- EFR Trusts Except Educational Religious and Charitable
- FULC Biotechnology: Pharmaceutical Preparations
- Sector
- EFR Finance
- FULC Health Care
- Exchange
- EFR Nasdaq
- FULC Nasdaq
- Market Cap
- EFR 344.0M
- FULC 372.2M
- IPO Year
- EFR N/A
- FULC 2019
- Fundamental
- Price
- EFR $11.67
- FULC $6.48
- Analyst Decision
- EFR
- FULC Buy
- Analyst Count
- EFR 0
- FULC 8
- Target Price
- EFR N/A
- FULC $7.13
- AVG Volume (30 Days)
- EFR 88.6K
- FULC 482.9K
- Earning Date
- EFR 01-01-0001
- FULC 07-29-2025
- Dividend Yield
- EFR 9.43%
- FULC N/A
- EPS Growth
- EFR N/A
- FULC N/A
- EPS
- EFR 1.69
- FULC N/A
- Revenue
- EFR N/A
- FULC N/A
- Revenue This Year
- EFR N/A
- FULC N/A
- Revenue Next Year
- EFR N/A
- FULC N/A
- P/E Ratio
- EFR $7.74
- FULC N/A
- Revenue Growth
- EFR N/A
- FULC 2752.05
- 52 Week Low
- EFR $10.95
- FULC $2.32
- 52 Week High
- EFR $13.29
- FULC $9.30
- Technical
- Relative Strength Index (RSI)
- EFR 39.66
- FULC 43.58
- Support Level
- EFR $11.64
- FULC $6.35
- Resistance Level
- EFR $11.79
- FULC $6.85
- Average True Range (ATR)
- EFR 0.09
- FULC 0.32
- MACD
- EFR 0.01
- FULC 0.01
- Stochastic Oscillator
- EFR 40.00
- FULC 24.69
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.